While more large employers are covering GLP-1 drugs for weight loss, KFF’s conversations with employers highlight concerns about the cost of these medications. Many of these employers have considered scaling back coverage of GLP-1 agonists for weight loss, or in some cases, employers are adding or strengthening coverage requirements.
Safaricom-Backed M-TIBA Victim of a Possible Data Breach Affecting Millions of Kenyans
Linet Amuli reports: Kenya’s digital health sector is facing a major cybersecurity crisis after hackers claimed to have stolen a massive trove of personal and
